Joint (JYNT) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Joint Revenue Highlights


Latest Revenue (Y)

$54.90M

Latest Revenue (Q)

$13.38M

Main Segment (Y)

Royalty

Joint Revenue by Period


Joint Revenue by Year

DateRevenueChange
2025-12-31$54.90M5.24%
2024-12-31$52.16M11.04%
2023-12-31$46.98M-53.60%
2022-12-31$101.25M26.55%
2021-12-31$80.01M36.34%
2020-12-31$58.68M21.12%
2019-12-31$48.45M52.41%
2018-12-31$31.79M26.33%
2017-12-31$25.16M22.61%
2016-12-31$20.52M48.34%
2015-12-31$13.84M94.41%
2014-12-31$7.12M19.45%
2013-12-31$5.96M113.94%
2012-12-31$2.78M-

Joint generated $54.90M in revenue during NA 2025, up 5.24% compared to the previous quarter, and up 93.55% compared to the same period a year ago.

Joint Revenue by Quarter

DateRevenueChange
2025-09-30$13.38M0.83%
2025-06-30$13.27M1.47%
2025-03-31$13.08M-134.16%
2024-12-31$-38.28M-226.78%
2024-09-30$30.20M139.48%
2024-06-30$12.61M3.49%
2024-03-31$12.18M-60.20%
2023-12-31$30.61M3.87%
2023-09-30$29.47M0.57%
2023-06-30$29.31M3.56%
2023-03-31$28.30M1.76%
2022-12-31$27.81M5.15%
2022-09-30$26.45M6.28%
2022-06-30$24.89M11.92%
2022-03-31$22.24M0.61%
2021-12-31$22.10M5.29%
2021-09-30$20.99M3.82%
2021-06-30$20.22M15.22%
2021-03-31$17.55M2.99%
2020-12-31$17.04M10.56%
2020-09-30$15.41M22.41%
2020-06-30$12.59M-7.73%
2020-03-31$13.64M-1.66%
2019-12-31$13.88M9.03%
2019-09-30$12.73M13.93%
2019-06-30$11.17M4.59%
2019-03-31$10.68M17.72%
2018-12-31$9.07M12.52%
2018-09-30$8.06M6.69%
2018-06-30$7.56M6.47%
2018-03-31$7.10M2.43%
2017-12-31$6.93M5.86%
2017-09-30$6.55M8.83%
2017-06-30$6.01M6.01%
2017-03-31$5.67M-1.85%
2016-12-31$5.78M5.04%
2016-09-30$5.50M10.65%
2016-06-30$4.97M16.62%
2016-03-31$4.27M13.35%
2015-12-31$3.76M-9.07%
2015-09-30$4.14M20.76%
2015-06-30$3.43M36.64%
2015-03-31$2.51M22.02%
2014-12-31$2.06M13.15%
2014-09-30$1.82M4.89%
2014-06-30$1.73M14.48%
2014-03-31$1.51M-8.45%
2013-12-31$1.65M12.20%
2013-09-30$1.47M-

Joint generated $13.38M in revenue during Q3 2025, up 0.83% compared to the previous quarter, and up 106.11% compared to the same period a year ago.

Joint Revenue Breakdown


Joint Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22Dec 21
Technology Service$6.04M$5.69M$5.09M$4.29M$3.38M
Advertising$10.45M$9.18M$8.32M$7.46M$6.30M
Franchise$3.37M$3.00M$2.88M$2.44M$2.66M
Product and Service, Other$1.83M$1.89M$1.53M$1.45M$1.26M
Royalty$33.20M$32.14M$29.16M$26.19M$22.06M
Revenues and Management Fees from Company Clinics--$70.72M$59.42M$44.35M
Regional Developer Fees---$659.10K$848.64K

Joint's latest annual revenue breakdown by segment (product or service), as of Dec 25: Royalty (60.49%), Advertising (19.04%), Technology Service (11.00%), Franchise (6.14%), and Product and Service, Other (3.34%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20
Technology Service$1.55M$1.55M$1.48M$1.46M$2.87M$1.43M$1.39M$1.34M$1.30M$1.23M$1.21M$1.12M$1.11M$1.10M$957.00K$996.31K$840.97K$786.04K$760.54K$729.55K
Royalty$8.89M$8.11M$8.13M$8.07M$16.69M$7.87M$7.59M$7.98M$7.14M$7.17M$6.87M$7.17M$6.60M$6.41M$6.01M$6.25M$5.71M$5.33M$4.77M$4.73M
Product and Service, Other$449.42K$418.81K$554.69K$408.62K$1.09M$407.13K$387.99K$409.04K$342.14K$384.96K$390.00K$392.72K$375.31K$370.56K$312.14K$372.58K$316.06K$310.07K$259.20K$255.66K
Franchise$810.09K$964.80K$768.10K$828.52K$344.72K$2.00M$655.87K$703.07K$754.03K$671.37K$754.42K$471.07K$642.40K$686.89K$640.97K$691.42K$648.60K$623.65K$695.43K$544.95K
Advertising$3.47M$2.34M$2.33M$2.31M$4.77M$2.25M$2.17M$2.28M$2.05M$2.04M$1.95M$2.04M$1.88M$1.83M$1.71M$1.78M$1.63M$1.52M$1.37M$1.33M
Revenues and Management Fees from Company Clinics-----$17.54M$17.54M$17.91M$17.88M$17.80M$17.13M$16.49M$15.84M$14.49M$12.61M$11.81M$11.63M$11.43M$9.47M$9.22M
Regional Developer Fees----------$149.48K$134.18K$153.18K$169.95K$201.79K$206.60K$209.65K$214.43K$217.96K$232.83K

Joint's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Royalty (58.63%), Advertising (22.85%), Technology Service (10.21%), Franchise (5.34%), and Product and Service, Other (2.96%).

Joint Revenue Breakdown by Country

Quarterly Revenue by Country

CountryMar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18Jun 18
Franchise$754.42K$471.07K$642.40K$686.89K$640.97K$691.42K$648.60K$623.65K$695.43K$544.95K$519.13K$523.96K$512.75K$385.87K$541.34K$447.27K$433.04K$457.52K$449.14K-
Revenues and Management Fees from Company Clinics$17.13M$16.49M$15.84M$14.49M$12.61M$11.81M$11.63M$11.43M$9.47M$9.22M$8.40M$6.86M$7.29M$7.56M$6.83M$5.78M$5.64M$3.67M$3.42M-
Technology Service$1.21M$1.12M$1.11M$1.10M$957.00K$996.31K$840.97K$786.04K$760.54K$729.55K$688.05K$631.20K$645.73K$609.07K$514.35K$377.13K$324.25K$315.91K--
Product and Service, Other$390.00K$392.72K$375.31K$370.56K$312.14K$372.58K$316.06K$310.07K$259.20K$255.66K$218.27K$164.95K$208.22K$203.32K$205.40K$176.45K$137.78K$124.74K--
Advertising$1.95M$2.04M$1.88M$1.83M$1.71M$1.78M$1.63M$1.52M$1.37M$1.33M$1.19M$930.79K$1.06M$1.09M$978.21K$927.80K$736.99K$687.75K--
Royalty$6.87M$7.17M$6.60M$6.41M$6.01M$6.25M$5.71M$5.33M$4.77M$4.73M$4.17M$3.27M$3.72M$3.82M$3.45M$3.26M$2.59M$2.42M--
Regional Developer Fees$149.48K$134.18K$153.18K$169.95K$201.79K$206.60K$209.65K$214.43K$217.96K$232.83K$222.91K$213.42K$207.64K$209.23K$210.23K$200.52K$184.29K$142.65K$137.41K-

Joint's latest quarterly revenue breakdown by geography, as of Mar 23: Revenues and Management Fees from Company Clinics (60.20%), Royalty (24.13%), Advertising (6.86%), Technology Service (4.25%), Franchise (2.65%), Product and Service, Other (1.37%), and Regional Developer Fees (0.53%).

Joint Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
DCGODocGo$322.20T$70.81T
LUCDLucid Diagnostics$4.35B$1.21B
BTMDbiote$192.22M$47.96M
CCLDCareCloud$120.50M$31.07M
JYNTJoint$54.90M$13.38M
APYXApyx Medical$52.10M$12.88M
RPIDRapid Micro Biosystems$33.59M$7.84M
SERASera Prognostics$77.00K$17.00K
CGTXCognition Therapeutics--
STSSSharps-$83.62K
IKTInhibikase Therapeutics--

JYNT Revenue FAQ


What is Joint’s yearly revenue?

Joint's yearly revenue for 2025 was $54.9M, representing an increase of 5.24% compared to 2024. The company's yearly revenue for 2024 was $52.16M, representing an increase of 11.04% compared to 2023. JYNT's yearly revenue for 2023 was $46.98M, representing a decrease of -53.60% compared to 2022.

What is Joint’s quarterly revenue?

Joint's quarterly revenue for Q3 2025 was $13.38M, a 0.83% increase from the previous quarter (Q2 2025), and a -55.69% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $13.27M, a 1.47% increase from the previous quarter (Q1 2025), and a 5.24% increase year-over-year (Q2 2024). JYNT's quarterly revenue for Q1 2025 was $13.08M, a -134.16% decrease from the previous quarter (Q4 2024), and a 7.33% increase year-over-year (Q1 2024).

What is Joint’s revenue growth rate?

Joint's revenue growth rate for the last 3 years (2023-2025) was 16.86%, and for the last 5 years (2021-2025) was -31.39%.

What are Joint’s revenue streams?

Joint's revenue streams in c 25 are Technology Service, Advertising, Franchise, Product and Service, Other, and Royalty. Technology Service generated $6.04M in revenue, accounting 11.00% of the company's total revenue, up 6.16% year-over-year. Advertising generated $10.45M in revenue, accounting 19.04% of the company's total revenue, up 13.84% year-over-year. Franchise generated $3.37M in revenue, accounting 6.14% of the company's total revenue, up 12.46% year-over-year. Product and Service, Other generated $1.83M in revenue, accounting 3.34% of the company's total revenue, down -2.91% year-over-year. Royalty generated $33.2M in revenue, accounting 60.49% of the company's total revenue, up 3.29% year-over-year.

What is Joint’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Joint was Royalty. This segment made a revenue of $33.2M, representing 60.49% of the company's total revenue.